CYB5R4


Summary: NCB5OR is a flavohemoprotein that contains functional domains found in both cytochrome b5 (CYB5A; MIM 613218) and CYB5 reductase (CYB5R3; MIM 613213) (Zhu et al., 1999 [PubMed 10611283]).[supplied by OMIM, Jan 2010].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

DRUGGABLE GENOME

GO terms in CYB5R4


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IDA GO:0004128 cytochrome-b5 reductase activity, acting on NAD(P)H
MF TAS GO:0004128 cytochrome-b5 reductase activity, acting on NAD(P)H
MF IDA GO:0016174 NAD(P)H oxidase activity
MF IDA GO:0016174 NAD(P)H oxidase activity
MF IBA GO:0016491 oxidoreductase activity
MF IDA GO:0016653 oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor
Showing 1 to 6 of 24 rows rows per page

Gene expression in normal tissue: CYB5R4

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

undefined36Apoptosis regulation3PI3K/MTOR signaling2Longevity regulating pathway1WNT signaling1Proteasome1ERK MAPK signaling1Stilbenoid, diarylheptanoid and gingerol biosynthesis1Chromatin histone acetylation1Metabolic pathways1

Pathways in CYB5R4


Loading, please wait...
Database
Pathway ID
Pathway Des.
kegg hsa00520 Amino sugar and nucleotide sugar metabolism - Homo sapiens (human)
wikipathways WP43 Oxidation by Cytochrome P450
reactome R-HSA-1237044 Erythrocytes take up carbon dioxide and release oxygen
reactome R-HSA-1480926 O2/CO2 exchange in erythrocytes
reactome R-HSA-382551 Transport of small molecules
Showing 1 to 5 of 5 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD505 Pevonedistat 2
iGMDRD552 AZD-1775 3
iGMDRD263 AACOCF3 3
iGMDRD147 Prima-1 1
Showing 1 to 4 of 48 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in CYB5R4

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​